Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light

Mark HJ Wessels, Charlotte E. Teunissen, Eva Strijbis et al.|Multiple Sclerosis Journal|2023

Cited by 17